[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369529-105":59,"doc-detail-369529-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","breast-cancer-incidence-in-sjogren-syndrome-patients-open-access-study","Breast Cancer Incidence in Sjögren Syndrome Patients - open access study","","Investigates breast cancer incidence risk in patients with Sjögren syndrome (SS) and primary Sjögren syndrome (pSS), addressing inconsistent findings across reports and exploring possible geographic effects. TriNetX data cover 2018–2022, comparing Sjögren and non-Sjögren cohorts after propensity score matching and estimating hazard ratios with 95% confidence intervals. Results show a slightly elevated but non-significant overall risk. Subgroup analyses identify higher risk in white and non-obese patients, including increased ER-positive breast cancer among white patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/breast-cancer-incidence-in-sjogren-syndrome-patients-open-access-study/369529/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/breast-cancer-incidence-in-sjogren-syndrome-patients-open-access-study/369529.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What dataset and study period were used to evaluate breast cancer incidence?","Question",{"text":112,"@type":113},"Data were retrieved from 1 January 2018 to 31 December 2022 using TriNetX. Breast cancer development was assessed as the outcome.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Did the study find any differences across patient subgroups?",{"text":117,"@type":113},"Subgroup analyses reported no differences in age, race, obesity, or diabetes mellitus status for certain comparisons. However, white and non-obese patients in the Sjögren cohort had significantly higher risk in overlapping sites.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the conclusions indicate about the relationship between SS/pSS and breast cancer risk?",{"text":121,"@type":113},"Neither SS nor pSS was significantly associated with an increased overall breast cancer risk. White patients in the Sjögren cohort showed significantly higher risk of ER-positive breast cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369529,1790219490,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nBreast Cancer Incidence in Sjögren Syndrome Patients  \nJih-Jin Tsai 1,2,3, Li-Teh Liu 4, Shiow-Ing Wang 5,6, * and James Cheng-Chung Wei 6,7,8,9, *  \nAcademic Editors: Marco Sebastiani and Margherita Sisto  \nReceived: 26 March 2025  \nRevised: 1 May 2025  \nAccepted: 13 May 2025  \nPublished: 16 May 2025  \nCitation: Tsai, J.-J.; Liu, L.-T.; Wang, S.-I.; Wei, J.C.-C. Breast Cancer Incidence in Sjögren Syndrome Patients. J. Clin. Med. 2025, 14, 3500 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)jcm14103500  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Tropical Medicine Center, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung 80756, Taiwan; [jijits@cc.kmu.edu.tw](jijits@cc.kmu.edu.tw)  \n2 Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung 80756, Taiwan  \n3 School of Medicine, College of Medicine, Kaohsiung Medical University, No. 100, Shiquan 1st Road, Sanmin District, Kaohsiung 807378, Taiwan  \n4 Department of Medical Laboratory Science and Biotechnology, College of Medical Technology, Chung Hwa University of Medical Technology, No. 89, Wunhua 1st Street, Rende District, Tainan 717302, Taiwan; [liult0119@mail.hwai.edu.tw](liult0119@mail.hwai.edu.tw)  \n5 Center for Health Data Science, Department of Medical Research, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo N. Road, South District, Taichung 40201, Taiwan  \n6 Institute of Medicine, Chung Shan Medical University, No. 110, Section 1, Jianguo N. Road, South District, Taichung 40201, Taiwan  \n7 Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, No. 110, Sec. 1, Jianguo N. Road, South District, Taichung 40201, Taiwan  \n8 Department of Nursing, Chung Shan Medical University, No. 110, Section 1, Jianguo N. Road, South District, Taichung 40201, Taiwan  \n9 Graduate Institute of Integrated Medicine, China Medical University, No. 110, Section 1, Jianguo N. Road, South District, Taichung 40201, Taiwan  \n* Correspondence: [cshe1301@csh.org.tw](cshe1301@csh.org.tw) (S.-I.W.); [jccwei@gmail.com](jccwei@gmail.com) (J.C.-C.W.)  \nAbstract: Background: The breast cancer risk profiles of SS (Sjögren syndrome) patients have shown inconsistent findings in different reports. A recent systematic review and meta-analysis indicated potential geographical variations in the link between pSS (primary Sjögren syndrome) and the risk of breast cancer. Patients with pSS from European countries exhibited a decreased likelihood of developing breast cancer, whereas an increased risk was observed in individuals from Asia and Argentina. A French study revealed that the incidence of breast cancer in pSS patients is lower. Therefore, we aimed to explore the incidence of breast cancer in SS or pSS through the TriNetX. Methods: Data were retrieved from 1 January 2018 to 31 December 2022 . The outcome was the development of breast cancer, and Sjögren and non-Sjögren cohorts were compared. The hazard ratio (HR) and its 95% confidence interval (CI) of the outcomes were determined. A total of 5103 patients were in each cohort after propensity score matching (PSM) . Results: We found a slightly but non-significantly elevated risk of breast cancer incidence in the Sjögren cohort (HR: 1.079, 95% CI: 0.765–1.522) . The subgroup analysis showed no difference in age, race, obesity, or diabetes mellitus status. We obtained similar findings in the sensitivity analyses for pSS patients and patients in different networks. The Sjögren cohort of white patients (3.343, 1.315–8.498) and non-obese patients (4.034, 1.309–12.42) ","cbCaioFArNSTp6UA","https://ap.wps.com/l/cbCaioFArNSTp6UA","pdf",586236,14,"English","# Abstract\n# Introduction","[{\"question\":\"What dataset and study period were used to evaluate breast cancer incidence?\",\"answer\":\"Data were retrieved from 1 January 2018 to 31 December 2022 using TriNetX. Breast cancer development was assessed as the outcome.\"},{\"question\":\"Did the study find any differences across patient subgroups?\",\"answer\":\"Subgroup analyses reported no differences in age, race, obesity, or diabetes mellitus status for certain comparisons. However, white and non-obese patients in the Sjögren cohort had significantly higher risk in overlapping sites.\"},{\"question\":\"What did the conclusions indicate about the relationship between SS/pSS and breast cancer risk?\",\"answer\":\"Neither SS nor pSS was significantly associated with an increased overall breast cancer risk. White patients in the Sjögren cohort showed significantly higher risk of ER-positive breast cancer.\"}]","Breast Cancer Incidence in Sjögren Syndrome Patients - open access study | PDF",1790183278,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0c6bc6fb73eca3ceb400cc7919e2dfe.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/505ded5b4f8fc374525d478137631e48.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bceda7e0f8737c7ea6591e89b9359f63.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/519835811ef0e461d114ce1474c8eafe.webp",980,1385]